Literature DB >> 18242048

Effects of an exercise challenge on mobilization and surface marker expression of monocyte subsets in individuals with normal vs. elevated blood pressure.

Suzi Hong1, Paul J Mills.   

Abstract

High blood pressure (BP) and monocyte activation are associated with atherogenic processes. Especially, CD16 expressing monocytes are shown to be activated in many inflammatory conditions but their characteristics in hypertension is unknown. We compared CD16(++), CD16(+) and CD16(-) monocyte populations and their cellular adhesion molecule (CAM), chemokine receptor, and activation marker expression in response to a moderate 20-min treadmill exercise bout at 65-70% V O(2peak) in 44 participants with elevated (EBP) or normal BP (NBP). Blood was drawn before, immediately after, and 10min after exercise. Phenotyping of monocytes and detection of surface markers were done by flow cytometry. Monocyte subset by exercise [pre, post, 10-min post] repeated measures ANOVA and group [EBP vs. NBP] by exercise repeated measures of ANCOVA with age, BMI, and fitness as covariates were employed. Circulating numbers of all the three monocyte subsets increased after exercise (p<0.001), with the largest % increase for CD16(+)CD14(++). Percents of CD16(++)CD14(+) and CD16(+)CD14(++) increased, whereas % CD16(-)CD14(++) decreased (p<0.001). Also, pre to post exercise changes in CD62L, CD11b, CXCR2, and HLA-DR expression were different among the monocyte subsets (p's<0.001). BP status did not significantly affect monocyte subset trafficking, although post-exercise changes in CD62L and CXCR2 levels were greater in EBP individuals (p<0.05). We conclude that exercise leads to a different mobilization among monocyte subsets based on CD16 expression. Individuals with high BP showed greater responses to a physical challenge in some monocyte chemokine receptors and selectins, but its clinical implications need further examination.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18242048      PMCID: PMC2485239          DOI: 10.1016/j.bbi.2007.12.003

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  32 in total

Review 1.  Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies.

Authors:  Victor J Dzau; Ruediger C Braun-Dullaeus; Daniel G Sedding
Journal:  Nat Med       Date:  2002-11       Impact factor: 53.440

2.  Identification of a novel dendritic cell-like subset of CD64(+) / CD16(+) blood monocytes.

Authors:  E Grage-Griebenow; R Zawatzky; H Kahlert; L Brade; H Flad; M Ernst
Journal:  Eur J Immunol       Date:  2001-01       Impact factor: 5.532

3.  Is there an association between angiotensin-converting enzyme gene polymorphism and functional activation of monocytes and macrophage in young patients with essential hypertension?

Authors:  Danuta Zapolska-Downar; Aldona Siennicka; Kornel Chełstowski; Krystyna Widecka; Iwona Goracy; Maciej Hałasa; Bogusław Machaliński; Marek Naruszewicz
Journal:  J Hypertens       Date:  2006-08       Impact factor: 4.844

4.  CD16+ and CD16- human blood monocyte subsets differentiate in vitro to dendritic cells with different abilities to stimulate CD4+ T cells.

Authors:  C Sánchez-Torres; G S García-Romo; M A Cornejo-Cortés; A Rivas-Carvalho; G Sánchez-Schmitz
Journal:  Int Immunol       Date:  2001-12       Impact factor: 4.823

5.  Selective mobilization of CD14(+)CD16(+) monocytes by exercise.

Authors:  B Steppich; F Dayyani; R Gruber; R Lorenz; M Mack; H W Ziegler-Heitbrock
Journal:  Am J Physiol Cell Physiol       Date:  2000-09       Impact factor: 4.249

6.  CD14+CD16++ cells derived in vitro from peripheral blood monocytes exhibit phenotypic and functional dendritic cell-like characteristics.

Authors:  P Ancuta; L Weiss; N Haeffner-Cavaillon
Journal:  Eur J Immunol       Date:  2000-07       Impact factor: 5.532

Review 7.  The burden of cardiovascular disease: following the link from hypertension to myocardial infarction and heart failure.

Authors:  Henry R Black
Journal:  Am J Hypertens       Date:  2003-09       Impact factor: 2.689

8.  Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes.

Authors:  James A de Lemos; David A Morrow; Marc S Sabatine; Sabina A Murphy; C Michael Gibson; Elliott M Antman; Carolyn H McCabe; Christopher P Cannon; Eugene Braunwald
Journal:  Circulation       Date:  2003-02-11       Impact factor: 29.690

9.  2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.

Authors: 
Journal:  J Hypertens       Date:  2003-06       Impact factor: 4.844

10.  The CD16(+) (FcgammaRIII(+)) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting.

Authors:  Gwendalyn J Randolph; Guzman Sanchez-Schmitz; Ronald M Liebman; Knut Schäkel
Journal:  J Exp Med       Date:  2002-08-19       Impact factor: 14.307

View more
  15 in total

1.  The impact of acute strenuous exercise on TLR2, TLR4 and HLA.DR expression on human blood monocytes induced by autologous serum.

Authors:  Stephen Booth; Geraint D Florida-James; Brian K McFarlin; Guillaume Spielmann; Daniel P O'Connor; Richard J Simpson
Journal:  Eur J Appl Physiol       Date:  2010-08-27       Impact factor: 3.078

2.  Exercise reduced pentraxin 3 levels produced by endotoxin-stimulated human peripheral blood mononuclear cells in obese individuals.

Authors:  Aaron L Slusher; Yoshimi Shibata; Michael Whitehurst; Arun Maharaj; Justin M Quiles; Chun-Jung Huang
Journal:  Exp Biol Med (Maywood)       Date:  2017-04-25

Review 3.  Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence.

Authors:  C J Hillard; K M Weinlander; K L Stuhr
Journal:  Neuroscience       Date:  2011-11-17       Impact factor: 3.590

Review 4.  Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications.

Authors:  Suzi Hong; William A Banks
Journal:  Brain Behav Immun       Date:  2014-10-22       Impact factor: 7.217

5.  Elevated blood levels of inflammatory monocytes (CD14+ CD16+ ) in patients with complex regional pain syndrome.

Authors:  B W Ritz; G M Alexander; S Nogusa; M J Perreault; B L Peterlin; J R Grothusen; R J Schwartzman
Journal:  Clin Exp Immunol       Date:  2011-02-08       Impact factor: 4.330

6.  Change of walking distance in intermittent claudication: impact on inflammation, oxidative stress and mononuclear cells: a pilot study.

Authors:  Jörn F Dopheide; Martin Scheer; Christopher Doppler; Viviane Obst; Pamela Stein; Markus Vosseler; Nico Abegunewardene; Tommaso Gori; Thomas Münzel; Andreas Daiber; Markus P Radsak; Christine Espinola-Klein
Journal:  Clin Res Cardiol       Date:  2015-03-15       Impact factor: 5.460

7.  Stress-induced changes in the expression of monocytic beta2-integrins: the impact of arousal of negative affect and adrenergic responses to the Anger Recall Interview.

Authors:  Jeffrey M Greeson; James G Lewis; Karen Achanzar; Eugene Zimmerman; Kenneth H Young; Edward C Suarez
Journal:  Brain Behav Immun       Date:  2008-10-08       Impact factor: 7.217

8.  Differential TNF production by monocyte subsets under physical stress: blunted mobilization of proinflammatory monocytes in prehypertensive individuals.

Authors:  Stoyan Dimitrov; Farah Shaikh; Christopher Pruitt; Michael Green; Kathleen Wilson; Nuzhat Beg; Suzi Hong
Journal:  Brain Behav Immun       Date:  2012-10-06       Impact factor: 7.217

9.  Beta-adrenergic receptor mediated inflammation control by monocytes is associated with blood pressure and risk factors for cardiovascular disease.

Authors:  Suzi Hong; Stoyan Dimitrov; Tiefu Cheng; Laura Redwine; Christopher Pruitt; Paul J Mills; Michael G Ziegler; J Michael Green; Farah Shaikh; Kathleen Wilson
Journal:  Brain Behav Immun       Date:  2015-08-20       Impact factor: 7.217

Review 10.  Influence of physical activity and nutrition on obesity-related immune function.

Authors:  Chun-Jung Huang; Michael C Zourdos; Edward Jo; Michael J Ormsbee
Journal:  ScientificWorldJournal       Date:  2013-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.